Ikonisys SA Asset Resilience Ratio
Ikonisys SA asset resilience ratio. Ikonisys SA (ALIKO) has an Asset Resilience Ratio of 0.13% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Ikonisys SA defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Ikonisys SA (2021–2022)
Asset resilience ratio of Ikonisys SA from 2021 to 2022. This chart shows how Ikonisys SA's Asset Resilience Ratio has changed over time. Read ALIKO total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Ikonisys SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Ikonisys SA.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €27.40K | 0.13% |
| Total Liquid Assets | €27.40K | 0.13% |
Asset Resilience Insights
- Limited Liquidity: Ikonisys SA maintains only 0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ikonisys SA Industry Peers by Asset Resilience Ratio
Compare Ikonisys SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607 |
Medical Devices | 16.21% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Ikonisys SA Asset Resilience Ratio by Year (2021–2022)
Ikonisys SA asset resilience ratio by year from 2021 to 2022. The table below shows the annual Asset Resilience Ratio data for Ikonisys SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 0.16% | €35.76K ≈ $41.81K |
€21.72 Million ≈ $25.39 Million |
-0.04pp |
| 2021-12-31 | 0.21% | €46.76K ≈ $54.67K |
€22.52 Million ≈ $26.33 Million |
-- |
About Ikonisys SA
Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the flu… Read more